Mawer Investment Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.4M Sell
187,293
-1,708
-0.9% -$633K 0.49% 49
2026
Q1
$55.3M Sell
189,001
-18,094
-9% -$5.95M 0.36% 61
2025
Q4
$72.6M Buy
207,095
+20,438
+11% +$6.91M 0.41% 53
2025
Q3
$60.3M Buy
186,657
+48,118
+35% +$15M 0.31% 63
2025
Q2
$53.9M Buy
+138,539
New +$55.7M 0.27% 66

Other funds holding ELV

Mawer Investment Management's ELV Position: Q2 2026 in Review

Mawer Investment Management reduced its Elevance Health (ELV) stake by 0.9% in Q2 2026, selling an estimated $633K and leaving 187,293 shares worth $72.4M. The position accounts for 0.49% of the portfolio, ranked #49.

Mawer Investment Management first reported a position in ELV in Q2 2025 and has held it in 5 quarters since. The position peaked at $72.6M in Q4 2025. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Mawer Investment Management held 187,293 shares of Elevance Health worth $72.4M as of Q2 2026.
  • Mawer Investment Management sold 1,708 Elevance Health shares in Q2 2026, an estimated $633K.
  • Elevance Health made up 0.49% of Mawer Investment Management's portfolio in Q2 2026, its #49 holding.
  • Mawer Investment Management first reported a position in Elevance Health in Q2 2025 and has held it in 5 quarters since.
  • Mawer Investment Management's Elevance Health position peaked at $72.6M in Q4 2025.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Mawer Investment Management's 13F filing for Q2 2026, filed 7 Aug 2026.